TP53 and endometrial carcinoma: Only 7% of endometrial carcinomas show a DNA mismatch repair protein (MMR) deficiency that is unrelated to MLH1 promoter hypermethylation [23], and as was previously indicated, TP53 mutations are uncommon in low grade endometrioid carcinoma [9].